DCGI计划扩大对包括疫苗在内的药物包装的QR编码要求,以打击假药。 DCGI plans to expand QR code requirement for drug packaging, including vaccines, to combat counterfeit medicines.

印度药品总长(药管总长)计划在2022年11月为打击假冒药品而建立的300个最初品牌之外,扩大药物包装的QR编码要求。 The Drugs Controller General of India (DCGI) plans to extend the QR code requirement for drug packaging beyond the initial 300 brands established in November 2022 to combat counterfeit medicines. 这一举措包括疫苗的强制性QR编码。 This initiative includes mandatory QR codes for vaccines. 中央毒品标准管制组织(药管组织)还下令对质量标准不达标的产品进行回收,并正在对违规行为采取遵守措施。 The Central Drug Standard Control Organisation (CDSCO) has also ordered recalls of products failing quality standards and is enforcing compliance measures against violations. 不久将在QR编码任务中增加进一步的产品。 Further products will be added to the QR code mandate soon.